Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 February 2019 | Story Zama Feni | Photo Charl Devenish
Disease Control and Prevention InStory
From left, seated: Dr Mathew Esona, CDC delegate; Dr Michael Bowen, CDC delegate; Dr Martin Nyaga, lead Researcher at the UFS-NGS Unit; standing: Mojalefa Buti, Office of the Vice-Dean, UFS Faculty of Health Sciences; Dr Glen Tylor, Senior Director, Directorate Research Development; Cornelius Hagenmeier, Director, Office for International Affairs; and Dr Saheed Sabiu, Postdoctoral Research Fellow in the Faculty of Natural and Agricultural Sciences.

In pursuit of efforts to advance research on viruses and disease control, the United States-based Centre for Disease Control and Prevention (CDC) has made a commitment to enhance the University of the Free State (UFS) Next Generation Sequencing (NGS) Unit’s data collection systems and further empower its staff and students.

UFS and US guests explore areas of mutual; cooperation

During a visit to the university in early December last year CDC delegation, Dr Michael Bowen and Dr Mathew Esona, a meeting was held with the lead Researcher at the UFS-NGS Unit, Dr Martin Nyaga; Senior Director of the UFS Directorate Research Development, Dr Glen Tylor; Director of UFS Office for International Affairs, Cornelius Hagenmeier; and Dr Saheed Sabiu Postdoctoral Research Fellow in the Faculty of Natural and Agriculture Sciences. It was in this meeting that areas of mutual collaboration and engagement between the two institutions which include technology transfer, funding and wet and dry laboratory quality control and capacity development were identified.

The UFS-NGS Unit, established in 2016, enjoys longstanding networking and collaborative ventures with renowned researchers in Africa, the USA, and Europe – which in return, have contributed immensely to the research activities of the university as a whole.

Dr Nyaga said in an effort to advance genomics research in the NGS Unit, the visitors have committed themselves to initiate and further enhance capacity development for the unit’s staff and students.

US guests impressed with advanced equipment at UFS

The CDC delegation were intrigued that the UFS also operates a Miseq Illumina platform like the one used at their enteric-viruses laboratory. It could thus be in line to assist in developing exclusive pipelines for the analysis of NGS data generated by the UFS-NGS Unit.

This is a personal sequencing system, which is a powerful state-of-the-art next-generation sequencer. It uses sequencing-by-synthesis technology capable of sequencing up to 15GB of high-quality filtered bases per run, with up to 600 base-pair read lengths. This allows the assembly of small genomes or the detection of target variants with unmatched accuracy, especially within homo-polymer regions.

UFS and CDC engagements still on

Further engagements about the identified areas of collaboration are ongoing between Hagenmeier, Dr Bowen, and Dr Nyaga, who are currently working on appropriate mechanisms to enact the envisaged collaboration between the two institutions.

The NGS Unit received research awards from the World Health Organisation, South African Medical Research Council, Poliomyelitis Research Foundation, and the National Research Foundation for different aspects of genomics research, and more recently from the Bill and Melinda Gates Foundation for the Enteric Viruses Genome Initiative, involving four African countries (South Africa, Ghana, Malawi, and Cameroon).

News Archive

Department Old Testament receives visiting professor from the USA
2009-05-19

 
Prof. Fanie Snyman (left) and Prof. Leder.


Prof. Arie Leder, professor in Old Testament at the Calvin Theological Seminary, Grand Rapids, Michigan in the United States of America (USA) set foot on the African continent for the first time when he visited Prof. Fanie Snyman of the Department Old Testament in the Faculty of Theology at the University of the Free State (UFS). Prof. Leder is a visiting professor at the Department of Old Testament.

During his two-week-long visit to the faculty he amongst others lectured to undergraduate and master’s students. The lectures addressed issues related to the first five books of the Old Testament with the focus on the interpretation of the Hebrew text. The mentioned historical books of the Old Testament were discussed with the postgraduate students of the faculty. During the meeting of the Discussion Group for Biblical Sciences, Prof. Leder presented a public lecture with the theme, “Lady Wisdom and Sir Folly: Preaching Esther for such a time as this”.

According to Prof. Snyman, the agreement with Prof. Leder was to present the same lectures as what he would have delivered at the Calvin Theological Seminary. “The aim was to compare the standards, course content and presentations of the lectures that are presented by the respective departments, with each other. We compare well with the Calvin Theological Seminary and we do not have to be ashamed of ourselves. The feedback of the students about the exposure to another lecturer from another institution was also positive,” said Prof. Snyman.

The possibility of future collaboration was also discussed, specifically with the objective of both institutions publishing articles in the respective journals of both institutions. A further positive result of Prof. Leder’s visit is that colleagues of the Calvin Theological Seminary will be approached to act as external examiners for postgraduate students,” said Prof. Snyman.

The Calvin Theological Seminary libraries are some of the best equipped theological libraries in the world and as a result of the collaboration between our two institutions, staff of this faculty will get the opportunity to visit the Calvin Institution and to utilise the facility.

Photo: Leonie Bolleurs

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept